###begin article-title 0
###xml 29 32 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
###end article-title 0
###begin p 1
Conceived and designed the experiments: DTE. Performed the experiments: BJ RSM JM SW. Analyzed the data: AR. Contributed reagents/materials/analysis tools: WN IBF WEJ. Wrote the paper: DTE.
###end p 1
###begin p 2
###xml 322 329 322 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm/mac</sub>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 469 472 469 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 476 479 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1301 1304 1301 1304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 191 196 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 330 335 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 542 556 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 698 703 <span type="species:ncbi:9606">human</span>
###xml 772 777 <span type="species:ncbi:9606">human</span>
###xml 910 913 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1001 1006 <span type="species:ncbi:9606">human</span>
###xml 1036 1039 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1155 1160 <span type="species:ncbi:9606">human</span>
###xml 1206 1211 <span type="species:ncbi:9606">human</span>
###xml 1306 1311 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1316 1321 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1385 1399 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 1404 1418 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 1468 1473 <span type="species:ncbi:9606">human</span>
###xml 1674 1677 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1718 1733 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 1738 1753 <span type="species:ncbi:9531">sooty mangabeys</span>
Tetherin, also known as BST2, CD317 or HM1.24, was recently identified as an interferon-inducible host-cell factor that interferes with the detachment of virus particles from infected cells. HIV-1 overcomes this restriction by expressing an accessory protein, Vpu, which counteracts tetherin. Since lentiviruses of the SIVsmm/mac/HIV-2 lineage do not have a vpu gene, this activity has likely been assumed by other viral gene products. We found that deletion of the SIVmac239 nef gene significantly impaired virus release in cells expressing rhesus macaque tetherin. Virus release could be restored by expressing Nef in trans. However, Nef was unable to facilitate virus release in the presence of human tetherin. Conversely, Vpu enhanced virus release in the presence of human tetherin, but not in the presence of rhesus tetherin. In accordance with the species-specificity of Nef in mediating virus release, SIV Nef downregulated cell-surface expression of rhesus tetherin, but did not downregulate human tetherin. The specificity of SIV Nef for rhesus tetherin mapped to four amino acids in the cytoplasmic domain of the molecule that are missing from human tetherin, whereas the specificity of Vpu for human tetherin mapped to amino acid differences in the transmembrane domain. Nef alleles of SIVsmm, HIV-2 and HIV-1 were also able to rescue virus release in the presence of both rhesus macaque and sooty mangabey tetherin, but were generally ineffective against human tetherin. Thus, the ability of Nef to antagonize tetherin from these Old World primates appears to be conserved among the primate lentiviruses. These results identify Nef as the viral gene product of SIV that opposes restriction by tetherin in rhesus macaques and sooty mangabeys, and reveal species-specificity in the activities of both Nef and Vpu in overcoming tetherin in their respective hosts.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 416 419 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 131 136 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 364 393 <span type="species:ncbi:11723">Simian immunodeficiency virus</span>
###xml 395 398 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 432 435 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 453 467 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 555 558 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 628 631 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 661 675 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 694 699 <span type="species:ncbi:9606">human</span>
###xml 726 731 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 757 762 <span type="species:ncbi:9606">human</span>
###xml 932 937 <span type="species:ncbi:9606">human</span>
###xml 983 988 <span type="species:ncbi:9606">human</span>
###xml 1103 1106 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Tetherin was recently identified as a host-cell factor that interferes with the detachment of virus particles from infected cells. HIV-1 overcomes the antiviral effects of tetherin by expressing Vpu, which mediates the degradation of tetherin. While tetherin has broad activity against diverse types of viruses, only a few of the primate AIDS viruses express Vpu. Simian immunodeficiency virus (SIV) does not have a vpu gene. Since SIV infection of the rhesus macaque is an important animal model for AIDS vaccine development, we set out to determine how SIV overcomes restriction by tetherin in this species. We found that the SIV Nef protein could counteract rhesus macaque tetherin, but not human tetherin. Conversely, the HIV-1 Vpu protein counteracted human tetherin, but not rhesus tetherin. The specificity of Nef for rhesus tetherin mapped to four amino acids in the cytoplasmic domain of the molecule that are missing from human tetherin, whereas the specificity of Vpu for human tetherin mapped to amino acid differences in the transmembrane domain. These observations identify a role for the SIV Nef protein in counteracting tetherin, and reveal species-specificity in the activities of both Nef and Vpu in overcoming tetherin in their respective hosts.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 206 209 206 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vpu</italic>
###xml 326 329 326 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Strebel1">[3]</xref>
###xml 330 333 330 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Strebel2">[4]</xref>
###xml 334 337 334 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Terwilliger1">[5]</xref>
###xml 338 341 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Klimkait1">[6]</xref>
###xml 342 345 342 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Geraghty1">[7]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Sakai1">[8]</xref>
###xml 518 521 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Klimkait1">[6]</xref>
###xml 522 525 522 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil2">[9]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Varthakavi1">[10]</xref>
###xml 621 624 621 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Klimkait1">[6]</xref>
###xml 625 628 625 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil2">[9]</xref>
###xml 725 728 725 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil2">[9]</xref>
###xml 729 733 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Varthakavi1">[10]</xref>
###xml 893 896 893 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 911 915 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Varthakavi1">[10]</xref>
###xml 995 1003 995 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;vpu</italic>
###xml 1022 1026 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Varthakavi1">[10]</xref>
###xml 1157 1160 1153 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil2">[9]</xref>
###xml 1161 1165 1157 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil3">[11]</xref>
###xml 1415 1418 1407 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 1435 1438 1427 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 1606 1610 1598 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bartee1">[12]</xref>
###xml 1701 1709 1693 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;vpu</italic>
###xml 1804 1807 1792 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 1935 1938 1923 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 238 243 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 905 910 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1429 1434 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1695 1700 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Efforts to elucidate the function of the HIV-1 Vpu protein recently led to the identification of an interferon-inducible, host-cell factor that interferes with the detachment of virions from infected cells [1],[2]. Vpu-deleted strains of HIV-1 exhibit a cell-type dependent defect in the release of virus particles from cells [3],[4],[5],[6],[7],[8]. In certain human cell lines, such as HeLa, Hep-2 and Jurkat cells, virus particles assemble and bud from the plasma membrane, but fail to detach from the cell surface [6],[9],[10]. These particles then become internalized where they accumulate in endosomal compartments [6],[9]. In other cell types, such as 293T, HOS and Cos-7 cells, Vpu is not required for virion release [9],[10]. Varthakavi and Spearman demonstrated that heterokaryon fusions of permissive and non-permissive cells exhibited a non-permissive phenotype for the release of vpu-deleted HIV-1 [10]. These experiments pointed to the presence of an inhibitor of virus release in Deltavpu-restrictive cells [10]. Subsequent studies revealed that the putative restriction factor was an interferon-inducible protein exposed on the cell surface [9],[11]. These observations quickly led Neil and Bieniasz to identify bone marrow stromal antigen 2 (BST2), also known as CD317 or HM1.24, from an expression analysis of IFNalpha-treated cells as the cellular gene product responsible for the restriction of vpu-deficient HIV-1 [1]. Based on a proteomic analysis of viral modulators of cell membrane proteins that was actually the first study to suggest a role for Vpu in the downmodulation of BST2 [12], Van Damme and Guatelli independently identified BST2 as the restriction factor for HIV-1 Deltavpu, and further demonstrated that Vpu-mediated downregulation of BST2 facilitated virion release [2]. For its role in inhibiting the detachment of virus particles from the surface of infected cells, BST2 was re-named "tetherin" [1].
###end p 6
###begin p 7
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kupzig1">[13]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Rollason1">[14]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kupzig1">[13]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Rollason1">[14]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kupzig1">[13]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Rollason1">[14]</xref>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kupzig1">[13]</xref>
###xml 775 779 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Aloia1">[15]</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Nguyen1">[16]</xref>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ono1">[17]</xref>
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Scheiffele1">[18]</xref>
###xml 795 799 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Panchai1">[19]</xref>
###xml 1004 1007 1004 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 1008 1011 1008 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 1012 1016 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Gottlinger1">[20]</xref>
###xml 1216 1219 1216 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 1220 1223 1220 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 1224 1227 1224 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil2">[9]</xref>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil3">[11]</xref>
###xml 1233 1237 1233 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Gottlinger1">[20]</xref>
###xml 730 735 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tetherin is an integral membrane protein with a number of peculiar features that suggests it plays a direct role in inhibiting the release of virions from infected cells. The N-terminus of the molecule is located in the cytoplasm, followed by a transmembrane domain and an extracellular coiled-coil domain [13],[14]. The C-terminus of the protein contains a predicted cleavage site for the addition of a glycosyl-phosphatidylinositol (GPI) anchor [13],[14]. Hence, tetherin is predicted to adopt an unusual topology in which both ends of the protein are anchored in the cell membrane [13],[14]. Tetherin also associates with cholesterol-rich lipid rafts [13], which have been implicated as sites of virus assembly and release for HIV-1 as well as for other enveloped viruses [15],[16],[17],[18],[19]. Thus, it has been proposed that tetherin may become incorporated into enveloped viruses as they attempt to bud from the cell surface and may prevent their release by bridging them to the plasma membrane [1],[2],[20]. Interactions between the cytoplasmic domain of tetherin and the cellular endocytosis machinery may then mediate the internalization of captured virions for degradation within endosomal compartments [1],[2],[9],[11],[20].
###end p 7
###begin p 8
###xml 50 53 50 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cpz</sub>
###xml 61 72 61 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsn/mon/mus</sub>
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Gao1">[21]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Courgnaud1">[22]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bailes1">[23]</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Courgnaud2">[24]</xref>
###xml 289 292 289 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Sakuma1">[25]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kaletsky1">[26]</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Jouvenet1">[27]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour1">[28]</xref>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ritter1">[29]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour2">[30]</xref>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Abada1">[31]</xref>
###xml 661 664 661 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 733 736 733 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Hirsch1">[32]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Chen1">[33]</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-MurpheyCorb1">[34]</xref>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Hahn1">[35]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Mansfield1">[36]</xref>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 432 437 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 648 653 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 742 757 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 761 767 <span type="species:ncbi:9606">humans</span>
###xml 777 792 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 796 811 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 924 927 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Among the primate lentiviruses, only the HIV-1/SIVcpz and SIVgsn/mon/mus lineages are known to have a vpu gene [21],[22],[23],[24]. Given evidence that tetherin has broad antiviral activity against a diverse range of enveloped viruses, including retroviruses, filoviruses and arenaviruses [1],[25],[26],[27], it is likely that other lentiviruses have also evolved countermeasures to overcome restriction by tetherin. In the case of HIV-2, the envelope glycoproteins of certain isolates have Vpu-like activity that can enhance the release of virions from restrictive cells [28],[29],[30],[31]. Phylogenetic and epidemiological evidence suggest that HIV-2 and SIVmac both originated as a result of the cross-species transmission of SIVsmm from sooty mangabeys to humans and from sooty mangabeys to rhesus macaques respectively [32],[33],[34],[35],[36]. The common origin of these viruses has therefore led to speculation that SIV may also use its envelope glycoprotein to overcome restriction by tetherin.
###end p 8
###begin p 9
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Sawyer1">[37]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Sawyer2">[38]</xref>
###xml 352 356 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Stremlau1">[39]</xref>
###xml 499 503 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Yap1">[40]</xref>
###xml 504 508 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Stremlau2">[41]</xref>
###xml 509 513 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Song1">[42]</xref>
###xml 514 518 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Hatziioannou1">[43]</xref>
###xml 668 672 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Sheehy1">[44]</xref>
###xml 673 677 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Zheng1">[45]</xref>
###xml 678 682 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Wiegand1">[46]</xref>
###xml 683 687 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Baumann1">[47]</xref>
###xml 842 846 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Schrfelbauer1">[48]</xref>
###xml 847 851 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Xu1">[49]</xref>
###xml 852 856 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bogerd1">[50]</xref>
###xml 1062 1066 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kupzig1">[13]</xref>
###xml 1067 1071 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-McNatt1">[51]</xref>
###xml 1185 1189 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-McNatt1">[51]</xref>
###xml 1190 1194 1182 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Goffinet1">[52]</xref>
###xml 306 311 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 336 351 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 737 742 <span type="species:ncbi:9606">human</span>
###xml 782 787 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
As a consequence of the ongoing evolutionary conflict between viral pathogens and host cell defenses, many antiviral restriction factors have acquired amino acid differences that are important host-range determinants of viral infection [37],[38]. TRIM5alpha was first identified as the post-entry block to HIV-1 infection of cells from rhesus macaques [39], and differences in the B30.2 (SPRY) domain of TRIM5alpha are now recognized as important host-range determinants of the primate lentiviruses [40],[41],[42],[43]. Likewise, species-specific differences in the APOBEC family of cytidine deaminases are significant host-range determinants for diverse retroviruses [44],[45],[46],[47]. A single amino acid difference in simian versus human APOBEC3G accounts for the inability of HIV-1 Vif to overcome this restriction in Old World monkeys [48],[49],[50]. Comparison of the amino acid sequences of tetherin orthologues from different mammalian species suggests that tetherin may also be rapidly evolving under positive selection in response to viral pathogens [13],[51]. Indeed, recent studies have now demonstrated that the ability of Vpu to antagonize tetherin is species-specific [51],[52].
###end p 9
###begin p 10
###xml 18 21 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 51 65 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 70 84 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 131 136 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 260 263 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
###xml 418 423 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 432 437 <span type="species:ncbi:9606">human</span>
Here we show that SIV Nef overcomes restriction by rhesus macaque and sooty mangabey tetherin, but not human tetherin. Conversely, HIV-1 Vpu counteracts restriction by human tetherin, but is ineffective against macaque or mangabey tetherin. The specificity of SIV Nef for rhesus tetherin mapped to a four amino acid sequence in the cytoplasmic domain that is missing from the human protein, whereas the specificity of HIV-1 Vpu for human tetherin mapped to amino acid differences in the trans-membrane domain. Thus, similar to TRIM5alpha and APOBEC3G, species-specific differences in tetherin may influence the host-range of primate lentiviruses.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 0 3 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
SIV Nef counteracts restriction by rhesus tetherin
###end title 12
###begin p 13
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 328 331 328 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 611 614 607 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 615 619 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil3">[11]</xref>
###xml 773 779 769 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g001">Fig. 1</xref>
###xml 20 23 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 198 203 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 309 314 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 403 408 <span type="species:ncbi:9606">human</span>
###xml 651 656 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 665 668 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Deletion mutants of SIV were tested for particle release in cells expressing tetherin to identify the viral gene product(s) that oppose this restriction factor. Wild-type and vpu-deleted strains of HIV-1 were also tested as controls. These assays were performed by transfection of 293T cells with full-length HIV-1 NL4-3 and SIVmac239 proviral DNA mutants together with expression constructs for either human or rhesus tetherin (hBST2 or rBST2). 293T cells were selected for these assays since previous studies have shown that these cells do not express endogenous tetherin in the absence of IFNalpha induction [1],[11]. Virus release was measured by HIV-1 p24 and SIV p27 antigen-capture ELISA at 0, 2, 20 and 200 ng of plasmid DNA for each tetherin expression construct (Fig. 1). Virion release for each strain was then compared as a percentage of maximal particle release in the absence of tetherin.
###end p 13
###begin title 14
###xml 51 54 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Identification of Nef as the viral gene product of SIV that counteracts restriction by tetherin.
###end title 14
###begin p 15
###xml 14 17 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 28 31 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 54 57 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 425 428 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 442 445 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 589 592 569 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 0 3 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 5 8 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 19 22 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 411 414 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 416 419 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 433 436 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 600 605 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 913 918 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 927 930 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
SIV, SIV Deltaenv, SIV Deltanef, HIV-1 and HIV-1 Deltavpu were tested for particle release in the presence of human (hBST2) and rhesus (rBST2) tetherin. Virus production as a percentage of maximal particle release in the absence of tetherin is shown at increasing amounts of plasmid DNA for hBST2 (A) and rBST2 (B). The mean and standard deviation (error bars) for total p27 release is also shown for wild-type SIV, SIV Deltaenv and SIV Deltanef at the indicated amounts of DNA for hBST2 (C) and rBST2 (D). 293T cells were transfected in duplicate with proviral DNA constructs based on SIVmac239 and HIV-1 NL4-3 together with expression constructs for either hBST2 or rBST2 (0, 2, 20 and 200 ng). Differences in the amount of plasmid DNA in each transfection were compensated by the addition of empty vector (pcDNA3). After 48 hours, the amount of virus released into the cell culture supernatant was measured by HIV-1 p24 and SIV p27 antigen-capture ELISA.
###end p 15
###begin p 16
###xml 40 48 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;vpu</italic>
###xml 123 130 119 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g001">Fig. 1A</xref>
###xml 132 135 128 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 136 139 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 297 305 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;vpu</italic>
###xml 307 314 299 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g001">Fig. 1A</xref>
###xml 562 569 554 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g001">Fig. 1B</xref>
###xml 601 604 593 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 672 679 664 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g001">Fig. 1B</xref>
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 116 121 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 156 159 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 291 296 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 323 326 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 378 383 <span type="species:ncbi:9606">human</span>
###xml 480 483 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 521 526 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 613 618 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 688 693 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 798 803 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 827 830 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 834 839 <span type="species:ncbi:9606">human</span>
Consistent with previous reports, HIV-1 Deltavpu was more sensitive to restriction by human tetherin than wild-type HIV-1 (Fig. 1A) [1],[2]. In the case of SIV, particle release for wild-type virus, and for each of the deletion mutants, was inhibited to a similar or greater extent than for HIV-1 Deltavpu (Fig. 1A). Thus, SIV appeared to be unable to counteract restriction by human tetherin. We therefore compared virion production in the presence of rhesus tetherin. Wild-type SIV was considerably more resistant than HIV-1 to restriction by rhesus tetherin (Fig. 1B). Moreover, both wild-type and vpu-deleted HIV-1 exhibited similar susceptibility to rhesus tetherin (Fig. 1B). Thus, HIV-1 also appeared to be unable to counteract restriction by rhesus tetherin. The inherent susceptibility of HIV-1 to rhesus tetherin and SIV to human tetherin suggested that the countermeasures used by these viruses were species-specific.
###end p 16
###begin p 17
###xml 101 109 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 142 150 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 205 212 197 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g001">Fig. 1B</xref>
###xml 275 283 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 357 365 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 392 399 376 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g001">Fig. 1A</xref>
###xml 434 445 418 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g001">Fig. 1C &amp; D</xref>
###xml 618 621 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 626 629 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpx</italic>
###xml 97 100 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 133 136 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 138 141 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 271 274 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 353 356 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 588 591 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 748 753 <span type="species:ncbi:9606">human</span>
###xml 845 848 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
In cells expressing rhesus tetherin, the greatest reduction in particle release was observed for SIV Deltanef. Compared to wild-type SIV, SIV Deltanef was inhibited 2- to 22-fold in the presence of rBST2 (Fig. 1B). A lesser 1.5- to 5-fold reduction was also observed for SIV Deltaenv. However, similar reductions in virus release were also observed for SIV Deltaenv in the presence of hBST2 (Fig. 1A), and in the absence of tetherin (Fig. 1C & D). Thus, it is unclear to what extent these differences may reflect additional non-specific effects of envelope on virus assembly and release. SIV mutants with deletions in vpr and vpx were also tested, but elimination of these genes did not significantly impair virus release in the presence of either human or rhesus tetherin (data not shown). These experiments therefore pointed to a role for the SIV Nef protein in overcoming restriction by rhesus tetherin.
###end p 17
###begin p 18
###xml 293 301 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 310 318 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 454 460 446 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g002">Fig. 2</xref>
###xml 633 644 625 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g002">Fig. 2A &amp; B</xref>
###xml 700 708 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 750 757 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g002">Fig. 2B</xref>
###xml 907 915 895 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 1045 1052 1029 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g002">Fig. 2B</xref>
###xml 1130 1138 1114 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 1324 1331 1304 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g002">Fig. 2B</xref>
###xml 153 156 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 284 287 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 289 292 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 306 309 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
###xml 696 699 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 895 898 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 903 906 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1118 1121 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1126 1129 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1377 1380 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
To confirm that these results were due to the effects of tetherin on particle release rather than on viral protein expression, we compared levels of the SIV p55 Gag protein in cells to the accumulation of p27 capsid in cell culture supernatant by western blot analysis. For wild-type SIV, SIV Deltaenv and SIV Deltanef, similar amounts of the p55 Gag protein were detected in cell lysates over a 0 to 50 ng range of plasmid DNA for both hBST2 and rBST2 (Fig. 2). In cells expressing human tetherin, there was a dose-dependent decrease in the accumulation of p27 recovered from the cell culture supernatant for each of these viruses (Fig. 2A & B). A similar reduction in p27 was also observed for SIV Deltanef at increasing levels of rhesus tetherin (Fig. 2B). These reductions in supernatant were accompanied by increases in cell-associated p27. However, p27 levels in supernatant for wild-type SIV and SIV Deltaenv were less sensitive to the effects of rhesus tetherin, as reflected by more consistent p27/p55 (supernatant/cell lysate) ratios (Fig. 2B). Although a partial reduction in p27 was observed for wild-type SIV and SIV Deltaenv under conditions of overexpression, suggesting that the ability to overcome restriction was saturable, the p27 band remained detectable even at 50 ng of the rBST2 expression construct (Fig. 2B). Thus, these results support a role for the SIV Nef protein in opposing the inhibition of vrus release by tetherin.
###end p 18
###begin title 19
###xml 48 51 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Dose-dependent reduction in the accumulation of SIV p27 in the cell culture supernatant relative to p55 Gag in cells at increasing expression levels of tetherin.
###end title 19
###begin p 20
###xml 139 147 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 161 164 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 296 304 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 317 320 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 20 23 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 130 133 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 135 138 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 152 155 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 287 290 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 292 295 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 308 311 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 759 763 <span type="species:ncbi:9925">goat</span>
###xml 769 774 <span type="species:ncbi:10090">mouse</span>
The accumulation of SIV p27 capsid in the cell culture supernatant relative to p55 Gag in cell lysates was compared for wild-type SIV, SIV Deltaenv and SIV Deltanef at increasing expression levels of human and rhesus tetherin. 293T cells were transfected with proviral DNA for wild-type SIV, SIV Deltaenv or SIV Deltanef together with 0, 2, 10 and 50 ng of plasmid DNA for hBST2 (A) or rBST2 (B). Forty-eight hours post-transfection, virus was recovered from the culture supernatant by centrifugation and cell lysates were prepared. Proteins were separated on a 10% SDS-polyacrylamide gel, transferred to a PVDF membrane and probed with monoclonal antibodies to p27/p55 Gag (183-H12-5C) and to BST2 (HM1.24). The blots were then probed with an HRP-conjugated goat anti-mouse secondary antibody, developed in chemiluminescent substrate and visualized using a Fujifilm Image Reader LAS 3000. Band intensities for p27 in virions and p55 in cell lysates were determined using the Image J Software (Rasband, W.S., Image, U.S. NIH, Bethesda, MD, , 1997-2008) and compared as p27/p55 ratios. 'ND' indicates that the p27 band was below the limit of detection.
###end p 20
###begin title 21
###xml 23 26 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specificity of SIV Nef and HIV-1 Vpu in counteracting restriction by tetherin
###end title 21
###begin p 22
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 225 233 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 252 255 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 402 406 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Morner1">[53]</xref>
###xml 476 487 472 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3A &amp; E</xref>
###xml 602 613 598 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3C &amp; G</xref>
###xml 825 842 821 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3B, D, F &amp; H</xref>
###xml 1020 1029 1016 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3A&#8211;H</xref>
###xml 16 19 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 221 224 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 238 243 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 276 281 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 909 914 <span type="species:ncbi:9606">human</span>
###xml 929 932 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1101 1106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1115 1118 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The capacity of SIV Nef and HIV-1 Vpu to restore particle release in trans in the presence of human and rhesus tetherin was tested to further investigate the species-specificity of these viral proteins. Virus release for SIV Deltanef and HIV-1 HXB2, a vpu-deficient strain of HIV-1, was measured by antigen-capture ELISA, and by infectivity on GHOST cells expressing CXCR4 and CCR5 (GHOST X4/R5 cells) [53]. The results of these assays are presented as total p24/p27 release (Fig. 3A & E), or as the frequency of infected cells following inoculation of GHOST X4/R5 cells with cell culture supernatant (Fig. 3C & G). The data are also presented as the percentage of maximal release in the absence of tetherin to control for additional effects of Nef and Vpu on particle release independent of their activity against tetherin (Fig. 3B, D, F & H). In each case, Vpu restored particle release in cells expressing human tetherin, and SIV Nef restored particle release in cells expressing rhesus tetherin, but not vice versa (Fig. 3A-H). Hence, these results confirmed the species-specific activity of both HIV-1 Vpu and SIV Nef in opposing restriction by tetherin.
###end p 22
###begin title 23
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 37 40 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Species-specificity of HIV-1 Vpu and SIV Nef in counteracting restriction by human and rhesus tetherin.
###end title 23
###begin p 24
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 96 99 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 106 109 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 264 267 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 386 387 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 401 402 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 398 402 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crm<sup>&#8722;</sup></italic>
###xml 418 419 410 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 428 429 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 425 429 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crm<sup>&#8722;</sup></italic>
###xml 532 535 524 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">129</sub>
###xml 539 542 531 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">133</sub>
###xml 549 552 541 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134</sub>
###xml 1254 1255 1246 1247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1262 1266 1254 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crm-</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 14 17 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 87 90 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 130 135 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 255 258 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 277 282 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 357 362 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 368 371 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 377 380 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 390 393 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 406 411 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 558 561 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 812 815 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 827 832 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1240 1243 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1268 1273 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1282 1287 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpu and SIV Nef were tested for the ability to rescue virus release in trans for SIV Deltanef and a vpu-deficient strain of HIV-1 in the presence of human and rhesus tetherin. 293T cells were transfected in duplicate with 100 ng of proviral DNA for SIV Deltanef (A-D) or HIV-1 HXB2 (E-H), 50 ng of DNA for hBST2 or rBST2, and 100 ng of DNA for either HIV-1 Vpu, SIV Nef, SIV Nef G2A, SIV Nef crm- or HIV-1 Nef. G2A and crm- represent amino acid substitutions in the myristoylation site and the cholesterol recognition motif (L129R, Y133A and Y134A) of SIV Nef respectively. Vector controls included pcDNA3 for the tetherin expression constructs and pCGCG for the Nef expression constructs. Forty-eight hours post-transfection, the amount of virus released into the cell culture supernatant was measured by SIV p27 (A) or HIV-1 p24 (E) antigen-capture ELISA, and by infectivity on GHOST X4/R5 cells (C,G). To control for variability due to tetherin-independent effects of Nef and Vpu on particle release, the data are also expressed as percent maximal release in the absence of tetherin (B,D,F,H). The values above each bar represent the fold-increase in virus release compared to the empty vector control. The expression of wild-type SIV Nef, Nef G2A, Nef crm-, HIV-1 Nef and HIV-1 Vpu were verified by western blot analysis (I).
###end p 24
###begin p 25
###xml 74 82 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 134 145 130 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3B &amp; F</xref>
###xml 234 245 230 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3D &amp; H</xref>
###xml 544 548 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Zheng2">[54]</xref>
###xml 624 625 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 804 810 800 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3</xref>
###xml 896 897 892 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 893 897 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crm<sup>&#8722;</sup></italic>
###xml 900 903 896 899 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">129</sub>
###xml 907 910 903 906 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">133</sub>
###xml 917 920 913 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134</sub>
###xml 1025 1029 1021 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Zheng2">[54]</xref>
###xml 1090 1096 1086 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3</xref>
###xml 1141 1142 1137 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1148 1151 1144 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crm</italic>
###xml 1151 1152 1147 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1305 1306 1301 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1302 1306 1298 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crm<sup>&#8722;</sup></italic>
###xml 1328 1335 1324 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3I</xref>
###xml 37 40 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 70 73 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 112 117 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 279 282 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 974 979 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1073 1076 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1211 1214 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1542 1545 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
In cells expressing rhesus tetherin, SIV Nef enhanced p27 release for SIV Deltanef 8.1-fold and p24 release for HIV-1 HXB2 12.5-fold (Fig. 3B & F). Similar corresponding increases were also observed in the amount of infectious virus (Fig. 3D & H). To verify that the activity of SIV Nef in counteracting rhesus tetherin was not the result of protein overexpression, Nef mutants with amino acid substitutions at positions predicted to broadly disrupt functional activities of Nef, without altering protein folding or stability, were also tested [54]. A glycine to alanine substitution in the N-terminal myristoylation site (G2A), which disrupts the localization of the protein to cellular membranes, significantly reduced the ability of Nef to facilitate virus release in the presence of rhesus tetherin (Fig. 3). Likewise, amino acid substitutions in a putative cholesterol recognition motif (crm-; L129R, Y133A and Y134A), previously reported to disrupt the association of HIV-1 Nef with cholesterol-rich lipid microdomains [54], completely abolished this activity of the SIV Nef protein (Fig. 3). Western blot analysis confirmed that the G2A and crm- mutants were expressed at similar levels to the wild-type SIV Nef protein, although a minor band representing a potential degradation product of the crm- mutant was observed (Fig. 3I). These results indicate that the activity of Nef in counteracting rhesus tetherin does not simply reflect a non-specific effect of protein overexpression. These results further suggest that the ability of SIV Nef to overcome restriction by rhesus tetherin may depend on its localization to cellular membranes.
###end p 25
###begin p 26
###xml 208 219 208 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3B &amp; F</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Sinclair1">[55]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Chowers1">[56]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Chowers2">[57]</xref>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Aiken1">[58]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Pizzato1">[59]</xref>
###xml 459 470 459 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3F &amp; H</xref>
###xml 549 557 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 65 70 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 110 113 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 153 158 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 370 375 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 482 487 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 545 548 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 561 566 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
###xml 617 622 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 700 705 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 725 731 <span type="species:ncbi:9606">humans</span>
###xml 906 911 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We also observed a partial effect of HIV-1 Nef on virus release. HIV-1 Nef resulted in a 3.8-fold increase in SIV p27 release and a 1.9-fold increase in HIV-1 p24 release in cells expressing rhesus tetherin (Fig. 3B & F). Consistent with the previously documented role for Nef in infectivity enhancement [55],[56],[57],[58],[59], this effect was greater (3.5-fold) when HIV-1 release was measured by infectivity on GHOST X4/R5 cells rather than by p24 ELISA (Fig. 3F & H). However, HIV-1 Nef did not significantly increase the release of either SIV Deltanef or HIV-1 HXB2 in cells expressing human tetherin. Although HIV-1 Nef activity against rhesus tetherin may seem at odds with the adaptation of HIV-1 for replication in humans, it is conceivable that conserved sequences in Nef, possibly maintained by virtue of their role in other functional activities of the protein, contribute to a basal level of HIV-1 Nef activity against rhesus tetherin.
###end p 26
###begin p 27
###xml 202 213 202 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3F &amp; H</xref>
###xml 437 444 437 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3G</xref>
###xml 504 512 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 514 525 510 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g003">Fig. 3B &amp; D</xref>
###xml 739 742 735 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 743 746 739 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 747 751 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Goffinet1">[52]</xref>
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 186 191 <span type="species:ncbi:9606">human</span>
###xml 253 258 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 500 503 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 638 643 <span type="species:ncbi:9606">human</span>
###xml 676 681 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 841 846 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In addition to facilitating particle release, Vpu also enhanced HIV-1 infectivity. While Vpu increased p24 release by 3.7-fold, infectivity was increased by 27.1-fold in the presence of human tetherin (Fig. 3F & H). This represents a 5-fold increase in HIV-1 particle infectivity. In contrast to the infectivity enhancement afforded by Nef, this effect was not observed in the absence of tetherin or in cells expressing rhesus tetherin (Fig. 3G). Furthermore, Vpu did not increase the infectivity of SIV Deltanef (Fig. 3B & D). Thus, the infectivity enhancement afforded by Vpu appears to be directly related to its role in counteracting human tetherin and to be specific for HIV-1. These results are consistent with previous observations [1],[2],[52], and suggest that Vpu may have an under appreciated role in enhancing the infectivity of HIV-1 that contributes to its activity in overcoming restriction by tetherin.
###end p 27
###begin title 28
###xml 4 7 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
The SIV envelope glycoprotein does not rescue virion release in the presence of human or rhesus tetherin
###end title 28
###begin p 29
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour1">[28]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ritter1">[29]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour2">[30]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Abada1">[31]</xref>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 443 446 443 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 474 490 474 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 698 702 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour2">[30]</xref>
###xml 703 707 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Abada1">[31]</xref>
###xml 742 746 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour2">[30]</xref>
###xml 747 751 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Abada1">[31]</xref>
###xml 877 883 869 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g004">Fig. 4</xref>
###xml 1227 1233 1219 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g004">Fig. 4</xref>
###xml 1337 1343 1329 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g004">Fig. 4</xref>
###xml 83 86 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 281 284 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 371 374 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 386 389 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 465 468 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 470 473 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 512 517 <span type="species:ncbi:9606">human</span>
###xml 604 609 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 648 653 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 682 687 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 753 758 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 817 822 <span type="species:ncbi:9606">human</span>
###xml 852 857 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 944 949 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1118 1123 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1135 1138 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1201 1206 <span type="species:ncbi:9606">human</span>
###xml 1249 1252 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1430 1433 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1479 1482 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Since deletion of the env gene resulted in a modest increase in the sensitivity of SIV to both human and rhesus tetherin, and the envelope glycoproteins of certain HIV-2 isolates have been shown to have Vpu-like activity [28],[29],[30],[31], we further examined the ability of the SIV envelope glycoprotein to oppose restriction by tetherin. The relative contribution of SIV Env versus SIV Nef to particle release was compared for an env- and nef-deleted strain of SIV (SIV DeltaenvDeltanef) in cells expressing human and rhesus tetherin. We also tested the envelope glycoproteins of two closely related HIV-2 isolates; one with Vpu-like activity, HIV-2 ROD10 Env, and one without, HIV-2 ROD14 Env [30],[31]. Consistent with previous reports [30],[31], HIV-2 ROD10 Env enhanced virus release in cells expressing both human and rhesus tetherin, whereas HIV-2 ROD14 Env did not (Fig. 4). These results suggest, perhaps not surprisingly, that the HIV-2 ROD10 envelope glycoprotein has a role in counteracting viral inhibition by tetherin, but unlike Vpu or Nef, this activity is not species-specific. However, similar to HIV-2 ROD14 Env, SIV Env failed to rescue virus release in cells expressing either human or rhesus tetherin (Fig. 4). In contrast, SIV Nef increased p27 release by more than 12-fold in cells expressing rhesus tetherin (Fig. 4). The inability to detect a significant increase in virus release under conditions of SIV Env overexpression further suggests that the SIV envelope glycoprotein does not play a major role in counteracting restriction by tetherin.
###end p 29
###begin title 30
###xml 18 21 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Expression of the SIV envelope glycoprotein does not rescue virus release.
###end title 30
###begin p 31
###xml 33 36 33 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 129 145 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 247 263 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 351 354 335 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 400 403 384 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 41 46 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 57 62 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 125 128 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 243 246 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 363 368 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 380 385 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 414 419 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 590 593 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 599 604 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 610 613 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 619 622 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 682 685 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 733 736 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 754 759 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 782 788 <span type="species:ncbi:9986">rabbit</span>
###xml 801 806 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 821 824 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 885 888 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The envelope glycoproteins of SIVmac239, HIV-2 ROD10 and HIV-2 ROD14 were tested for the ability to rescue virus release for SIV DeltaenvDeltanef in cells expressing human and rhesus tetherin. 293T cells were transfected with proviral DNA for SIV DeltaenvDeltanef, an expression construct for hBST2 or rBST2, and an expression construct for either SIVmac239 Env, HIV-2 ROD10 Env, HIV-2 ROD14 Env, SIVmac239 Nef or HIV-1 NL4-3 Vpu. The mean and standard deviation (error bars) are shown for total p27 release (A) and for percent maximal release (B). (C) Protein expression was confirmed for SIV Env, HIV-2 Env, SIV Nef, SIV p55 Gag and BST2 by western blot analysis of cell lysates. SIV Env was detected with a monoclonal antibody to SIV gp120 (KK42) and HIV-2 Env was detected with rabbit antisera to HIV-2 ST gp120. The SIV Nef protein was detected with the monoclonal antibody 17.2. SIV p55 Gag, BST2 and beta-actin were detected with the monoclonal antibodies 183-H12-5C, HM1.24 and C4 respectively. Following incubation with an appropriate HRP-conjugated secondary antibody, the blots were developed in chemiluminescent substrate and visualized using a Fujifilm Image Reader LAS 3000.
###end p 31
###begin title 32
###xml 0 3 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
SIV Nef downregulates rhesus tetherin from the cell surface
###end title 32
###begin p 33
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Roeth1">[60]</xref>
###xml 132 135 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 578 579 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 652 653 652 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 837 843 837 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g005">Fig. 5</xref>
###xml 1057 1063 1057 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g005">Fig. 5</xref>
###xml 1087 1090 1087 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 154 157 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 186 200 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 271 276 <span type="species:ncbi:9606">human</span>
###xml 757 760 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 821 826 <span type="species:ncbi:9606">human</span>
###xml 1092 1095 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Since Nef is known to downregulate a number of proteins from the cell surface [60], and Vpu has been shown to downregulate tetherin [2], we asked whether SIV Nef could also downregulate rhesus macaque tetherin. To address this question, stable 293T cell lines expressing human and rhesus tetherin with HA tags in their extracellular domains were transfected with bicistronic constructs that co-express Nef together with green fluorescent protein (GFP). The extent of tetherin downmodulation was determined by comparing the mean fluorescence intensity (MFI) of HA-staining on GFP+ cells transfected with the empty vector to the MFI of HA-staining on GFP+ cells expressing Nef. Consistent with the species-specific activity of Nef in mediating virus release, SIV Nef downregulated rhesus tetherin, but did not downregulate human tetherin (Fig. 5). Moreover, mutations in the myristoylation site and putative cholesterol recognition motif that impaired the ability of Nef to facilitate virus release also disrupted its ability to downregulate rhesus tetherin (Fig. 5). Thus, similar to Vpu [2], SIV Nef appears to specifically downmodulate cell-surface expression of rhesus tetherin.
###end p 33
###begin title 34
###xml 0 3 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
SIV Nef downregulates rhesus tetherin, but not human tetherin.
###end title 34
###begin p 35
###xml 251 252 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crm<sup>&#8722;</sup></italic>
###xml 373 376 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</italic>
###xml 454 457 454 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 861 862 861 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 233 236 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 242 245 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 258 261 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 666 672 <span type="species:ncbi:9793">donkey</span>
###xml 678 683 <span type="species:ncbi:10090">mouse</span>
The ability of Nef to downmodulate tetherin from the cell surface was assessed by transfecting stable 293T cell lines expressing HA-tagged human or rhesus tetherin (hBST2 or rBST2) with bicistronic constructs expressing Nef and GFP. SIV Nef, SIV Nef G2A and SIV Nef crm- were expressed from the same mRNA transcript as GFP using pCGCG constructs in which expression of the GFP reporter gene was driven from an internal ribosomal entry site downstream of nef. Cells were also transfected with pCGCG without nef as an empty vector control. Twenty-four hours after transfection, the cells were stained with an anti-HA monoclonal antibody followed by an APC-conjugated, donkey anti-mouse polyclonal antibody and analyzed by flow cytometry. The values indicated in each plot represent the mean fluorescence intensity and standard deviation of HA/BST2 staining on GFP+ cells for duplicate transfections.
###end p 35
###begin title 36
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 68 71 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 89 103 <span type="species:ncbi:9544">rhesus macaque</span>
Interferon induces tetherin and inhibits the release of nef-deleted SIV from an infected rhesus macaque cell line
###end title 36
###begin p 37
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 264 272 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 284 300 276 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 483 490 463 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g006">Fig. 6A</xref>
###xml 561 569 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 578 594 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 661 677 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 695 703 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 725 741 677 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 805 812 745 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g006">Fig. 6B</xref>
###xml 842 845 782 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 77 80 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 90 104 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 260 263 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 280 283 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 557 560 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 574 577 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 657 660 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 691 694 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 721 724 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 838 841 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
To determine if deletion of the nef gene also impaired virus release from an SIV-infected rhesus macaque cell line expressing physiological levels of tetherin, sMAGI cells, cultured in the presence and absence of IFNalpha, were infected with VSV G-pseudotyped SIV Deltaenv versus SIV DeltaenvDeltanef. While this cell line did not express dectable levels of tetherin in the absence of interferon, treatment with IFNalpha resulted in the upregulation of tetherin on the cell surface (Fig. 6A). Although IFNalpha significantly impaired virus release for both SIV Deltaenv and SIV DeltaenvDeltanef, we observed a much greater reduction in particle release for SIV DeltaenvDeltanef. Compared to SIV Deltaenv, p27 release for SIV DeltaenvDeltanef was reduced an additional 13.8-fold in IFNalpha-treated cells (Fig. 6B). Hence, deletion of the SIV nef gene significantly impaired virus release from infected cells in the presence of interferon.
###end p 37
###begin title 38
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 68 71 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 89 103 <span type="species:ncbi:9544">rhesus macaque</span>
Interferon induces tetherin and inhibits the release of nef-deleted SIV from an infected rhesus macaque cell line.
###end title 38
###begin p 39
###xml 166 174 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 186 202 178 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 445 448 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 601 609 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 618 634 586 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 4 18 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 162 165 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 182 185 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 441 444 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 597 600 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 614 617 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The rhesus macaque sMAGI cell line was cultured in the presence or absence of IFNalpha, and virus release was compared following infection with VSV G-pseudotyped SIV Deltaenv versus SIV DeltaenvDeltanef. (A) Treatment with IFNalpha upregulated the expression of tetherin on the cell surface. Cells were cultured in medium with or without 1000 U/ml IFNalpha, and the expression of tetherin was assessed by flow cytometry. (B) Deletion of the SIV nef gene significantly impaired virus release from infected cells in the presence of IFNalpha. Seventy-two hours after infection with VSV G-pseudotyped SIV Deltaenv and SIV DeltaenvDeltanef (50 ng/ml p27 eq. each), the amount of p27 released into the cell culture supernatant was determined by antigen capture ELISA.
###end p 39
###begin title 40
###xml 19 22 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
The specificity of SIV Nef for rhesus tetherin maps to a four amino acid sequence in the N-terminus of the molecule that is not present in human tetherin
###end title 40
###begin p 41
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 271 274 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 280 283 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 420 425 <span type="species:ncbi:9606">human</span>
###xml 487 490 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Since Nef is a membrane-associated cytosolic protein, we reasoned that it could potentially associate with the cytoplasmic domain of tetherin. We therefore exchanged the cytoplasmic domains of human and rhesus tetherin and tested these recombinants for susceptibility to SIV Nef. SIV Nef restored particle release when the cytoplasmic domain of rhesus tetherin was fused to the transmembrane and extracellular domain of human tetherin, but not vice versa, indicating that the ability of SIV Nef to antagonize rhesus tetherin was dependent on sequences in the cytoplasmic domain (data not shown).
###end p 41
###begin p 42
###xml 214 221 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g007">Fig. 7A</xref>
###xml 366 373 366 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g007">Fig. 7B</xref>
###xml 711 712 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 713 714 713 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 715 716 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 746 747 746 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 748 749 748 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 750 751 750 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 828 835 828 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g007">Fig. 7C</xref>
###xml 961 968 957 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g007">Fig. 7C</xref>
###xml 130 135 <span type="species:ncbi:9606">human</span>
###xml 205 208 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 694 699 <span type="species:ncbi:9606">human</span>
###xml 1078 1081 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Amino acid substitutions were therefore introduced into the cytoplasmic domain of rhesus tetherin at positions that differed from human tetherin to further define the sequences required for recognition by SIV Nef (Fig. 7A). Western blot analysis confirmed the expression of each of these mutants, although there appeared to be some variability in protein detection (Fig. 7B). Repeated analysis of the same samples indicated that these differences in band intensity were in part due to inconsistencies in the detergent solubility of this transmembrane protein, and thus do not reflect quantitative levels of protein expression. Substitution of amino acids 3-5 with the corresponding residues of human tetherin (S3T4S5), or with alanine residues (A3A4A5), diminished, but did not eliminate, the effect of Nef on particle release (Fig. 7C). Furthermore, deletion of the first 10 amino acids (Delta10) did not affect the ability of Nef to facilitate virus release (Fig. 7C). These results therefore implicated the remaining 16-residue membrane proximal region in recognition by the SIV Nef protein.
###end p 42
###begin title 43
###xml 78 81 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Identification of the residues in rhesus tetherin required for recognition by SIV Nef.
###end title 43
###begin p 44
###xml 182 184 178 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 188 190 184 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 245 247 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 251 253 247 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 561 569 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 494 497 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 557 560 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
(A) Amino acid substitutions were introduced into full-length rBST2 and a deletion mutant lacking the first ten amino acids (rBST2 Delta10) at positions that differ from hBST2. The G14DIWK18 motif of rBST2 was also introduced into hBST2 (hBST2 G14DIWK18). Dashes represent sequence gaps, and positions that differ from wild-type rBST2 are indicated in red. (B) Expression of each of the rBST2 mutants tested in (C) was confirmed by western blot analysis of transfected 293T cell lysates. (C,D) SIV Nef was tested for the ability to rescue virus release for SIV Deltanef in cells expressing each of the rBST2 and hBST2 mutants shown in (A). Transfection and assay conditions were the same as previously described.
###end p 44
###begin p 45
###xml 346 353 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g007">Fig. 7A</xref>
###xml 409 411 405 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 412 414 408 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sub>
###xml 428 430 424 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 431 433 427 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sub>
###xml 541 543 537 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 544 546 540 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">19</sub>
###xml 557 564 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g007">Fig. 7C</xref>
###xml 686 688 682 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 689 691 685 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sub>
###xml 697 699 693 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 700 702 696 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sub>
###xml 783 785 779 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 786 788 782 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">19</sub>
###xml 810 817 806 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g007">Fig. 7D</xref>
###xml 855 857 851 853 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 861 863 857 859 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 968 975 964 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g007">Fig. 7D</xref>
###xml 1013 1015 1009 1011 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 1018 1020 1014 1016 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sub>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 896 901 <span type="species:ncbi:9606">human</span>
###xml 1092 1097 <span type="species:ncbi:9606">human</span>
###xml 1154 1157 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The most conspicuous difference between rhesus and human tetherin in this region was a five amino acid sequence that is missing from the human molecule. Alanine substitutions were introduced into this region in the context of the Delta10 truncation mutant to investigate the possibility that these sequences accounted for the specificity of Nef (Fig. 7A). Pair wise alanine substitutions at positions 14-15 (A14A15) and 16-17 (A16A17) eliminated the ability of Nef to enhance virus release, while adjacent substitutions at positions 18-19 (A18A19) did not (Fig. 7C). These substitutions were also introduced into full-length rhesus tetherin, and similar to the truncation mutants, the A14A15 and A16A17 substitutions abrogated the ability of Nef to rescue virion release, while the A18A19 substitions did not (Fig. 7D). Moreover, the introduction of the G14DIWK18 motif from rhesus tetherin into human tethern resulted in a gain-of-function for susceptibility to Nef (Fig. 7D). Thus, a four amino acid sequence, G14DIW17, that is present in the cytoplasmic domain of rhesus tetherin, but not human tetherin, accounts for the species-specific activity of SIV Nef against rhesus tetherin.
###end p 45
###begin title 46
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
The specificity of HIV-1 Vpu maps to the membrane-spanning domain of human tetherin
###end title 46
###begin p 47
###xml 345 352 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g008">Fig. 8A</xref>
###xml 451 458 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g008">Fig. 8B</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
Recombinants between human and rhesus tetherin were also tested to identify sequence differences that accounted for the species-specificity of Vpu. Sequences coding for the cytoplasmic domains were exchanged to generate rN/hBST2 and hN/rBST2 and sequences coding for the transmembrane domains were exchanged to generate rTM/hBST2 and hTM/rBST2 (Fig. 8A). The expression of each of these chimeric fusion proteins was verified by western blot analysis (Fig. 8B). These recombinants were then tested for the ability to inhibit virus release in the presence and absence of Vpu.
###end p 47
###begin title 48
###xml 46 51 <span type="species:ncbi:9606">human</span>
The sequences required for Vpu recognition of human tetherin map to the transmembrane domain.
###end title 48
###begin p 49
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 578 583 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Sequences corresponding to the cytoplasmic domain (N) and transmembrane domain (TM) of human and rhesus tetherin (hBST2 and rBST2) were exchanged to generate the chimeric fusion proteins rTM/hBST2, hTM/rBST2, rN/hBST2 and hN/rBST2. Amino acid sequences corresponding to the predicted transmembrane domains are boxed, dashes represent sequence gaps, and positions in hBST2 that differ from rBST2 are indicated in red. (B) The expression of each of these recombinant proteins was verified by western blot analysis. (C) Vpu was tested for the ability to rescue p24 release for HIV-1 HXB2 in 293T cells expressing hBST2, rBST2, rTM/hBST2, hTM/rBST2, rN/hBST2 and hN/rBST2. Transfection and assay conditions were the same as described previously.
###end p 49
###begin p 50
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g008">Fig. 8C</xref>
###xml 596 603 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g008">Fig. 8C</xref>
###xml 820 827 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g008">Figs 8C</xref>
###xml 1085 1089 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Paul1">[61]</xref>
###xml 1090 1094 1090 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Tiganos1">[62]</xref>
###xml 1095 1099 1095 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Schubert1">[63]</xref>
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 727 732 <span type="species:ncbi:9606">human</span>
###xml 916 921 <span type="species:ncbi:9606">human</span>
Vpu restored particle release for the rN/hBST2 chimera, in which the cytoplasmic domain of human tetherin was exchanged with the cytoplasmic domain of rhesus tetherin, but not for the reciprocal hN/rBST2 chimera (Fig. 8C). Thus, the specificity of Vpu was not affected by exchanging the cytoplasmic domains of hBST2 and rBST2. However, susceptibility to Vpu was reversed by exchanging their transmembrane domains. Replacement of the transmembrane domain of human tetherin with the corresponding sequences from rhesus tetherin (rTM/hBST2) abrogated the ability of Vpu to facilitate virus release (Fig. 8C). For the reciprocal exchange, replacement of the transmembrane domain of rhesus tetherin with the transmembrane domain of human tetherin (hTM/rBST2) resulted in a gain-of-function for Vpu-mediated particle release (Figs 8C). Hence, these experiments mapped the specificity of Vpu to the transmembrane domain of human tetherin. Since Vpu is also an integral membrane protein, and membrane-spanning sequences at its N-terminus are required for the ability to enhance virion release [61],[62],[63], these results suggest that the mechanism by which Vpu antagonizes tetherin may involve interactions between the transmembrane domains of these proteins.
###end p 50
###begin title 51
###xml 18 25 18 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm/mac</sub>
###xml 27 32 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 54 68 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 73 87 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 136 141 <span type="species:ncbi:9606">human</span>
Nef alleles of SIVsmm/mac, HIV-2 and HIV-1 counteract rhesus macaque and sooty mangabey tetherin, but are generally ineffective against human tetherin
###end title 51
###begin p 52
###xml 18 25 18 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm/mac</sub>
###xml 183 186 183 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 225 228 225 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 242 245 242 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 257 260 257 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 333 344 333 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g009">Fig. 9B &amp; C</xref>
###xml 461 464 461 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 473 484 473 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g009">Fig. 9B &amp; C</xref>
###xml 623 630 623 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g009">Fig. 9D</xref>
###xml 791 798 791 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g009">Fig. 9D</xref>
###xml 934 937 934 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 27 32 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 118 132 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 134 148 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 308 322 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 411 425 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 647 652 <span type="species:ncbi:9606">human</span>
###xml 654 668 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 673 687 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 943 958 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 962 977 <span type="species:ncbi:9544">rhesus macaques</span>
Nef alleles of SIVsmm/mac, HIV-2 and HIV-1 were tested for the ability to rescue particle release in cells expressing rhesus macaque, sooty mangabey and human tetherin. Similar to SIVmac239 Nef, Nef alleles of two primary SIVsmm isolates, SIVsmmFYr1 and SIVsmmFWr1, enhanced virus release in the presence of rhesus macaque tetherin (Fig. 9B & C). These alleles also enhanced virus release from cells expressing sooty mangabey tetherin to a similar extent as SIVmac239 Nef (Fig. 9B & C). These observations are supported by western blots showing consistent levels of Nef and p55 Gag expression in each set of transfections (Fig. 9D). The bands for human, rhesus macaque and sooty mangabey tetherin were more variable, but nevertheless provided qualitative verification of protein expression (Fig. 9D). These results therefore suggest that the ability of Nef to oppose tetherin was likely retained upon cross-species transmission of SIVsmm from sooty mangabeys to rhesus macaques.
###end p 52
###begin title 53
###xml 18 25 18 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm/mac</sub>
###xml 27 32 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 54 68 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 73 87 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
Nef alleles of SIVsmm/mac, HIV-2 and HIV-1 counteract rhesus macaque and sooty mangabey tetherin, but not human tetherin.
###end title 53
###begin p 54
###xml 18 25 18 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm/mac</sub>
###xml 106 114 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 576 583 572 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm/mac</sub>
###xml 816 819 812 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 830 833 826 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 27 32 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 102 105 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 158 172 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 194 208 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 585 590 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 595 600 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 685 688 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 704 709 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 889 892 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 902 917 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 922 925 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 935 950 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 985 990 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1062 1067 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1110 1115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1161 1167 <span type="species:ncbi:9986">rabbit</span>
###xml 1178 1181 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Nef alleles of SIVsmm/mac, HIV-2 and HIV-1 were tested for the ability to rescue particle release for SIV Deltanef in the presence of human tetherin (hBST2), rhesus macaque tetherin (rBST2) and sooty mangabey tetherin (sBST2). (A) The amino acid sequences corresponding to the cytoplasmic domains of hBST2, rBST2 and sBST2 are shown. Dashes represent sequence gaps and residues that differ from rBST2 are indicated in red. The mean and standard deviation (error bars) for total p27 release (B) and for percent maximal release (C) are shown for the indicated Nef alleles of SIVsmm/mac, HIV-2 and HIV-1 in the presence of hBST2, rBST2 and sBST2. (D) Protein expression was confirmed for SIV p55 Gag, BST2, HIV-1 Vpu and for each of the Nef alleles by western blot analysis of 293T cell lysates. The Nef proteins of SIVmac239 and SIVsmm (FYr1 and FWr1) were detected using plasma pooled from SIV-infected rhesus macaques and SIV-infected sooty mangabeys respectively. The Nef proteins of HIV-2 ROD10, ROD14, CBL-23 and 60415K were detected using plasma pooled from HIV-2-infected individuals. The Nef proteins of HIV-1 NL4-3 and NA7 were detected using polyclonal rabbit antisera. SIV p55 Gag, BST2 and beta-actin were detected with the monoclonal antibodies 183-H12-5C, HM1.24 and C4. Following incubation with an appropriate HRP-conjugated secondary antibody, the blots were developed in chemiluminescent substrate and visualized using a Fujifilm Image Reader LAS 3000.
###end p 54
###begin p 55
###xml 157 168 157 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g009">Fig. 9B &amp; C</xref>
###xml 590 601 590 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g009">Fig. 9B &amp; C</xref>
###xml 712 713 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sub>
###xml 714 716 714 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 797 804 797 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000429-g009">Fig. 9A</xref>
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 61 66 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 113 127 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 132 146 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 343 348 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 444 449 <span type="species:ncbi:9606">human</span>
###xml 475 480 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 565 579 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 637 651 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 656 670 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
###xml 771 785 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 844 849 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 883 888 <span type="species:ncbi:9606">human</span>
###xml 948 962 <span type="species:ncbi:9531">sooty mangabey</span>
Although somewhat less efficiently, Nef alleles of HIV-1 and HIV-2 also rescued virus release in the presence of rhesus macaque and sooty mangabey tetherin (Fig. 9B & C). Thus, the ability of Nef to counteract tetherin from these Old World monkeys appears to be broadly conserved among the primate lentiviruses. However, with the exception of HIV-1 NA7 Nef, none of the Nef alleles tested appreciably restored virus release in cells expressing human tetherin. Interestingly, HIV-1 NA7 Nef was particularly effective at facilitating virus release in the presence of sooty mangabey tetherin (Fig. 9B & C). Since the cytoplasmic domains of rhesus macaque and sooty mangabey tetherin only differ by two amino acids C9R10, and these residues are present in both the human and sooty mangabey molecules (Fig. 9A), it is conceivable that adaptation of HIV-1 NA7 for partial activity against human tetherin may have resulted in greater activity against the sooty mangabey molecule.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 216 219 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 299 302 299 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 303 306 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Jouvenet1">[27]</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Sakuma1">[25]</xref>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kaletsky1">[26]</xref>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Jouvenet1">[27]</xref>
###xml 439 442 439 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cpz</sub>
###xml 450 461 450 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsn/mon/mus</sub>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Gao1">[21]</xref>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Courgnaud1">[22]</xref>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bailes1">[23]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Courgnaud2">[24]</xref>
###xml 538 545 538 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm/mac</sub>
###xml 568 571 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 142 147 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 430 435 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 529 534 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 843 846 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 881 895 <span type="species:ncbi:9544">rhesus macaque</span>
Tetherin (BST2, CD317 or HM1.24) was recently identified as an interferon-inducible restriction factor that interferes with the detachment of HIV-1 from infected cells in the absence of the Vpu accessory protein [1],[2]. While this factor appears to have broad activity against diverse retroviruses [1],[2],[27], as well as other families of enveloped viruses [25],[26],[27], only two phylogenetic groups of primate lentiviruses, HIV-1/SIVcpz and SIVgsn/mon/mus, are known to express Vpu [21],[22],[23],[24]. Lentiviruses of the HIV-2/SIVsmm/mac lineage do not have a vpu gene. Thus, understanding how these viruses overcome restriction by tetherin is of significant evolutionary interest and may have important implications to our understanding of the host-range specificity of the primate lentiviruses. We therefore set out to determine how SIV overcomes this restriction in the rhesus macaque, an important animal model for lentiviral pathogenesis and for AIDS vaccine development.
###end p 57
###begin p 58
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 157 165 157 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 746 750 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Yap1">[40]</xref>
###xml 751 755 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Stremlau2">[41]</xref>
###xml 756 760 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Song1">[42]</xref>
###xml 761 765 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Hatziioannou1">[43]</xref>
###xml 766 770 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Schrfelbauer1">[48]</xref>
###xml 771 775 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Xu1">[49]</xref>
###xml 776 780 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bogerd1">[50]</xref>
###xml 52 55 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 118 121 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 141 144 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 295 298 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 327 330 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 384 389 <span type="species:ncbi:9606">human</span>
###xml 415 420 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 454 459 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 509 514 <span type="species:ncbi:9606">human</span>
###xml 598 603 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 612 615 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 867 872 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 877 880 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
In the presence of rhesus tetherin, deletion of the SIV nef gene greatly impaired virus release compared to wild-type SIV. Expression of the SIV Nef protein in trans rescued virus release from cells expressing rhesus tetherin, thereby suggesting a role for Nef in overcoming this restriction in SIV-infected macaques. However, SIV Nef did not enhance virus release in the presence of human tetherin. In the case of HIV-1 Vpu, the situation was reversed. HIV-1 Vpu facilitated virus release in the presence of human tetherin, but not in the presence of rhesus tetherin. Thus, the activities of both HIV-1 Vpu and SIV Nef in counteracting restriction by tetherin are species-specific. These results suggest that, similar to TRIM5alpha and APOBEC3G [40],[41],[42],[43],[48],[49],[50], species-specific differences in tetherin contribute to the host-range specificity of HIV-1 and SIV.
###end p 58
###begin p 59
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour1">[28]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ritter1">[29]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour2">[30]</xref>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Abada1">[31]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kaletsky1">[26]</xref>
###xml 16 19 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 269 274 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 579 582 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 697 702 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 795 798 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 885 888 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 981 984 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Deletion of the SIV env gene also impaired virus release from cells transfected with proviral DNA. Compared to the deletion of nef, this effect was lower and did not appear to be specific for either human or rhesus tetherin. Since the envelope glycoproteins of certain HIV-2 isolates, such as ROD10 and ST, have Vpu-like activity that can enhance the release of diverse retroviruses from otherwise restrictive cell types [28],[29],[30],[31], and the Ebola glycoprotein was recently shown to counteract tetherin [26], this raised the possibility that the envelope glycoprotein of SIV might also antagonize restriction by tetherin. However, under conditions of envelope overexpression, in which the HIV-2 ROD Env could partially rescue particle release, we did not observe a significant effect of SIV Env on virus release. While these results do not preclude a minor contribution of the SIV envelope glycoprotein, they suggest that Nef is the predominant viral gene product by which SIV counteracts restriction by tetherin.
###end p 59
###begin p 60
###xml 86 88 86 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 91 93 91 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sub>
###xml 204 206 204 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 210 212 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ishikawa1">[64]</xref>
###xml 392 394 392 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 398 400 398 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-The1">[65]</xref>
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-The1">[65]</xref>
###xml 19 22 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
###xml 308 313 <span type="species:ncbi:9606">human</span>
###xml 321 331 <span type="species:ncbi:9598">chimpanzee</span>
###xml 448 458 <span type="species:ncbi:9598">chimpanzee</span>
###xml 566 572 <span type="species:ncbi:9606">humans</span>
###xml 577 588 <span type="species:ncbi:9598">chimpanzees</span>
###xml 715 720 <span type="species:ncbi:9606">human</span>
###xml 859 862 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 945 950 <span type="species:ncbi:9606">human</span>
The specificity of SIV Nef for rhesus tetherin mapped to a four amino acid sequence, G14DIW17, in the cytoplasmic domain of the molecule. These residues closely coincide with a five amino acid sequence, G14DIWK18, that is missing from human tetherin [64]. Comparison of the predicted amino acid sequences of human versus chimpanzee tetherin revealed that a similar five amino acid sequence (D14DIWK18) was retained in the cytoplasmic domain of the chimpanzee orthologue [65]. This suggests that a recent 15-nucleotide deletion, that occurred since the divergence of humans and chimpanzees from a common ancestor approximately 5 million years ago [65], accounts for the inability of Nef to counteract restriction by human tetherin. It is therefore tempting to speculate that our ancestors may have encountered a viral pathogen, perhaps a lentivirus related to SIV, that selected for the loss of these sequences at some point during the course of human evolutionary history.
###end p 60
###begin p 61
###xml 166 169 166 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 400 403 400 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Hirsch1">[32]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-MurpheyCorb1">[34]</xref>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Mansfield1">[36]</xref>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour1">[28]</xref>
###xml 1233 1237 1233 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ritter1">[29]</xref>
###xml 1238 1242 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour2">[30]</xref>
###xml 1243 1247 1243 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Abada1">[31]</xref>
###xml 26 29 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 111 125 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 304 307 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 409 424 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 428 443 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 511 516 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 521 526 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 587 601 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 606 620 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 1029 1034 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1085 1090 <span type="species:ncbi:9606">human</span>
###xml 1213 1218 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
The residues required for SIV Nef recognition of rhesus tetherin are also present in the cytoplasmic domain of sooty mangabey tetherin, and Nef alleles of primary SIVsmm isolates were able to overcome restriction by tetherin orthologues from both of these Old World primate species. Thus, the ability of SIV Nef to oppose tetherin appears to have been conserved upon cross-species transmission of SIVsmm from sooty mangabeys to rhesus macaques [32],[34],[36]. Although somewhat less efficiently, Nef alleles of HIV-1 and HIV-2, were also able to rescue virus release in cells expressing sooty mangabey and rhesus macaque tetherin. These observations suggest that conserved sequences in Nef, maintained perhaps as a consequence of their role in other functional activities, may contribute to a basal level of activity against macaque and mangabey tetherin. However, consistent with the absence of sequences in the cytoplasmic domain essential for recognition by Nef, none of the Nef alleles tested, with the possible exception of HIV-1 NA7 Nef, rescued virus release in the presence of human tetherin. Hence, this may explain why this activity appears to have been assumed by the envelope glycoproteins of certain HIV-2 isolates [28],[29],[30],[31].
###end p 61
###begin p 62
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Aloia1">[15]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Nguyen1">[16]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ono1">[17]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Scheiffele1">[18]</xref>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Panchai1">[19]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Wang1">[66]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Zheng3">[67]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kupzig1">[13]</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 568 571 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
HIV-1, and other enveloped viruses, assemble and bud from cholesterol-rich lipid rafts at the plasma membrane [15],[16],[17],[18],[19]. Nef localizes to lipid rafts and increases virus budding and infectivity [66],[67]. Since tetherin also associates with lipid rafts by virtue of its GPI anchor [13], the ability of Nef to counteract tetherin may be dependent on its association with cellular membranes and targeting to lipid rafts. Consistent with this possibility, amino acid substitutions in the myristoylation site and a putative cholesterol recognition motif of SIV Nef impaired its ability to counteract rhesus tetherin.
###end p 62
###begin p 63
###xml 622 625 622 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 100 103 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 256 259 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 607 612 <span type="species:ncbi:9606">human</span>
###xml 705 708 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Although the mechanism by which Nef counteracts tetherin remains to be fully defined, we found that SIV Nef could downregulate rhesus tetherin from the cell surface. As with the ability to rescue particle release, this activity was species-specific, since SIV Nef was unable to downregulate human tetherin. Furthermore, mutations in the myristoylation site and cholesterol recognition motif that impaired the ability of Nef to facilitate virus release also disrupted its ability to downmodulate rhesus tetherin. These results suggest that, similar to the previously documented ability of Vpu to dowmodulate human tetherin [2], the downregulation of rhesus tetherin by Nef may contribute to the ability of SIV to overcome this restriction in Old World primates.
###end p 63
###begin p 64
###xml 73 76 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 258 266 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;vpu</italic>
###xml 292 296 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil3">[11]</xref>
###xml 302 310 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 438 441 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 613 617 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Sinclair1">[55]</xref>
###xml 660 668 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 791 792 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 85 88 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 106 120 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 191 205 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 252 257 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
###xml 298 301 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 491 494 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 566 569 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 656 659 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Treatment with IFNalpha upregulated tetherin and impaired the release of nef-deleted SIV from an infected rhesus macaque cell line. These results confirmed that the expression of tetherin on rhesus macaque cells is interferon-inducible, and similar to HIV-1 Deltavpu infection of human cells [11], SIV Deltanef is particularly sensitive to IFNalpha. Regulation of tetherin by interferon may explain, at least in part, why deletion of the nef gene does not result in a more complete block to SIV replication in primary PBMC. While Nef clearly confers an advantage to SIV replication in primary macaque lymphocytes [55], depending on the culture conditions, SIV Deltanef can replicate nearly as well as wild-type virus. In the absence of interferon, low basal levels of tetherin on primary CD4+ lymphocytes may not impose a stringent barrier to virus replication.
###end p 64
###begin p 65
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kestler1">[68]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Desrosiers1">[69]</xref>
###xml 219 227 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 318 322 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kestler1">[68]</xref>
###xml 627 631 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Benson1">[70]</xref>
###xml 670 674 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-DeGottardi1">[71]</xref>
###xml 696 700 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Alexander1">[72]</xref>
###xml 730 734 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Pizzato1">[59]</xref>
###xml 956 964 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 139 142 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 146 161 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 215 218 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 314 317 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 952 955 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
A role for Nef in overcoming restriction by tetherin may, nevertheless, help to explain the attenuated phenotype of nef-deleted strains of SIV in rhesus macaques [68],[69]. Peak viral loads in animals infected with SIV Deltanef are typically 1.5 logs lower than peak viral loads in animals infected with wild-type SIV [68]. Greater susceptibility to inhibition by tetherin may contribute to this attenuated phenotype, particularly during the acute phase of infection prior to the onset of adaptive immunity. However, the loss of a number of other functional activities of Nef may also play a role, including CD4 downregulation [70], selective MHC class I downregulation [71], cellular activation [72], and infectivity enhancement [59]. Additional studies to differentiate the role of Nef in opposing tetherin from its other functional activities will be necessary to ascertain the relative importance of the loss of this activity to the attenuation of SIV Deltanef.
###end p 65
###begin p 66
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 111 114 111 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 135 138 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 262 269 262 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Alexander2">[73]</xref>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Alexander2">[73]</xref>
###xml 747 755 747 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 870 873 866 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 877 881 873 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Alexander2">[73]</xref>
###xml 1374 1378 1370 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Pizzato1">[59]</xref>
###xml 1379 1383 1375 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Alexander1">[72]</xref>
###xml 1454 1462 1450 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 34 62 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 150 155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 174 179 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 222 225 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 426 431 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 578 583 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 743 746 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 971 976 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1078 1083 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1124 1127 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1129 1134 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1226 1231 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1450 1453 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1621 1624 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Infection of macaques with simian-human immunodeficiency virus (SHIV) strains in which the nef sequences of SIVmac239 were replaced by nef alleles of HIV-1 demonstrated that HIV-1 Nef can, at least in part, substitute for SIV Nef to facilitate virus replication in vivo. Of 19 animals infected with these SHIVnef strains, 11 maintained moderate to high viral loads and 8 progressed to AIDS within 1-2 years of infection [73]. HIV-1 nef sequences were retained in all animals and sequence changes predicted to optimize translation were observed suggesting that the expression of HIV-1 Nef conferred an advantage to virus replication [73]. Nevertheless, while the viral loads in these animals were generally higher than in animals infected with SIV Deltanef, they were not as high, or as consistent, as viral loads typically observed in animals infected with wild-type SIVmac239 [73]. This intermediate phenotype is consistent with our present observations indicating that HIV-1 Nef is poorly adapted for counteracting viral inhibition by rhesus tetherin. Although Nef alleles of HIV-1 were less effective than Nef alleles of SIV, HIV-1 Nef appears to have a basal level of activity against rhesus tetherin. Partial activity of HIV-1 Nef against rhesus tetherin, together with other conserved activities of the protein, such as cellular activation and infectivity enhancement [59],[72], may account for the replicative advantage of SHIVnef relative to SIV Deltanef. However, incomplete adaptation to rhesus tetherin may also have contributed to the somewhat more attenuated phenotype of these viruses compared to wild-type SIV.
###end p 66
###begin p 67
###xml 28 31 28 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 32 35 32 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 36 40 36 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Goffinet1">[52]</xref>
###xml 235 243 235 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 1017 1020 1017 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil1">[1]</xref>
###xml 1021 1025 1021 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Neil3">[11]</xref>
###xml 1329 1333 1329 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme2">[74]</xref>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 389 394 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
###xml 518 523 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Similar to previous reports [1],[2],[52], we observed a greater effect of Vpu when HIV-1 release was measured by an infectivity assay than by an assay for viral antigen. In the presence of human tetherin, expression of the Vpu protein in trans resulted in a 27.1-fold increase in the amount of infectious virus versus a 3.7-fold increase in the amount of p24 for a vpu-deficient strain of HIV-1. Unlike the infectivity enhancement afforded by Nef, this effect was dependent on human tetherin and was only observed for HIV-1. Hence, this activity appears to be directly related to the role of Vpu in overcoming restriction by tetherin. This suggests that, in addition to facilitating the detachment of virus particles from infected cells, Vpu may also play a role in infectivity enhancement. One possibility is it that Vpu-mediated downregulation and degradation of tetherin may prevent the incorporation of tetherin into virions and reduce the formation of viral aggregates, as suggested by some electron micrographs [1],[11]. This would effectively increase the titer of infectious virus, since more particles would be available to infect a greater number of cells. Alternatively, the observed increase in infectivity may be related to the recently reported effect of Vpu on preventing the accumulation of Env in late endosomes [74]. By inhibiting Env transport to endosomes, Vpu may facilitate the incorporation of Env into virions assembling at the plasma membrane, thereby increasing particle infectivity.
###end p 67
###begin p 68
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Paul1">[61]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Tiganos1">[62]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Schubert1">[63]</xref>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 320 323 320 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-VanDamme1">[2]</xref>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 787 791 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-McNatt1">[51]</xref>
###xml 372 377 <span type="species:ncbi:9606">human</span>
###xml 486 491 <span type="species:ncbi:9606">human</span>
###xml 754 759 <span type="species:ncbi:9606">human</span>
Vpu has a transmembrane anchor at its N-terminus, and mutations within this region disrupt its ability to facilitate virion release [61],[62],[63]. Van Damme et al. further demonstrated that the correct amino acid sequence of the Vpu transmembrane domain is required for downmodulation of tetherin from the cell surface [2]. By exchanging the membrane-spanning domains of human and rhesus tetherin, we mapped the sequences responsible for Vpu recognition to the transmembrane domain of human tetherin. This finding was independently verified by McNatt et al. in a recent study showing that a combination of amino acid differences within the transmembrane domain, rather a single amino acid subsitution, accounted for differences in the susceptibility of human and rhesus tetherin to Vpu [51]. These results suggest that the mechanism by which Vpu antagonizes tetherin likely requires specific interactions, either direct or via a bridging factor, between the transmembrane domains of Vpu and tetherin.
###end p 68
###begin p 69
###xml 360 364 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Hatziioannou2">[75]</xref>
###xml 365 369 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kamada1">[76]</xref>
###xml 461 465 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Hatziioannou2">[75]</xref>
###xml 466 470 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kamada1">[76]</xref>
###xml 550 554 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Igarashi1">[77]</xref>
###xml 555 559 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Hatziioannou3">[78]</xref>
###xml 879 886 871 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 111 116 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 199 204 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 306 311 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 331 334 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 441 460 <span type="species:ncbi:9545">pig-tailed macaques</span>
###xml 783 788 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1133 1138 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1162 1167 <span type="species:ncbi:9606">human</span>
The inability of Vpu to counteract restriction by rhesus tetherin represents a potential additional barrier to HIV-1 replication in macaques. Efforts to overcome the known species-specific blocks to HIV-1 infection of macaques imposed by TRIM5alpha and APOBEC3G have led to the construction of recombinant HIV-1 strains containing SIV capsid and Vif sequences [75],[76]. These chimeric viruses replicate efficiently in PBMCs from rhesus and pig-tailed macaques [75],[76], but are unable to sustain persistent, high-level virus replication in animals [77],[78]. Unlike APOBEC3G and TRIM5alpha, tetherin does not represent an absolute block to infection, but may serve to attenuate virus replication in the absence of effective viral countermeasures. Thus, the susceptibility of these HIV-1 recombinants to restriction by tetherin, perhaps under conditions of interferon-induction in vivo, may contribute to the inability of these viruses to replicate efficiently in animals. The introduction of additional sequence changes to overcome restriction by tetherin in macaques therefore represents a promising approach for further adapting HIV-1 for replication in non-human primates.
###end p 69
###begin title 70
Materials and Methods
###end title 70
###begin title 71
Plasmid DNA constructs
###end title 71
###begin title 72
(i) BST 2 expression constructs
###end title 72
###begin p 73
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BST2</italic>
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hBST2</italic>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BST2</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rBST2</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BST2</italic>
###xml 247 250 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ho1">[79]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 102 116 <span type="species:ncbi:9544">Rhesus macaque</span>
###xml 121 135 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
###xml 548 553 <span type="species:ncbi:9606">human</span>
Human BST2 (hBST2) was amplified by PCR from a cDNA clone obtained from the Harvard Plasmid Database. Rhesus macaque and sooty mangabey BST2 (rBST2) were amplified by RT-PCR from mRNA isolated from lymphocytes. BST2 sequences were cloned into the Kpn I and Xho I sites of pcDNA3 (Invitrogen, Carlsbad, CA). Amino acid substitutions were introduced into rhesus BST2 by QuickChange site-directed mutagenesis (Stratagene, La Jolla, CA) of pcDNA3-rBST2. Recombinants of human and rhesus tetherin were generated by PCR overlap extension [79] using both human and rhesus tetherin as template and cloned into pcDNA3. All plasmid DNA expression constructs were sequence confirmed.
###end p 73
###begin title 74
###xml 5 10 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 15 18 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
(ii) HIV-1 and SIV clones
###end title 74
###begin p 75
###xml 26 29 26 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 37 40 37 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 49 52 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 57 60 53 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 69 72 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 80 83 72 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 92 95 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 100 103 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 216 219 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Env</italic>
###xml 241 244 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 244 248 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kestler1">[68]</xref>
###xml 249 253 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Kestler2">[80]</xref>
###xml 254 258 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Regier1">[81]</xref>
###xml 259 263 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Jia1">[82]</xref>
###xml 409 413 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Adachi1">[83]</xref>
###xml 419 422 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 459 467 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;vpu</italic>
###xml 507 510 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 850 853 822 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 883 886 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tat</italic>
###xml 891 894 863 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 894 898 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Fisher1">[84]</xref>
###xml 899 903 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Ratner1">[85]</xref>
###xml 265 270 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 440 445 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 453 458 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 699 704 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Full-length clones for SIVmac239, SIVmac239 Deltaenv, SIVmac239 Deltanef and SIVmac239 DeltaenvDeltanef were constructed from previously described deletion mutants based on p239SpSp5', pSP72-239-3', pSP72-239-3'DeltaEnv and pSP72-239-3'Deltanef[68],[80],[81],[82]. HIV-1 NL4-3 (pNL4-3) was obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH from Dr. Malcolm Martin [83]. The vpu-deleted clone of HIV-1 NL4-3 (HIV-1 Deltavpu) was made by deleting nucleotide 16 of vpu, which resulted in a frame shift followed by multiple in-frame stop-codons. This clone was provided by Dr. Swee Kee Wong (New England Primate Research Center, Harvard Medical School). The HIV-1 HXB2 clone pHXB2 does not express Vpu as a result of a defective ACG start-codon. This clone also contains an additional frame shift mutation in vpr and premature stop-codons in tat and nef[84],[85].
###end p 75
###begin title 76
(iii) Nef, Vpu and Env expression constructs
###end title 76
###begin p 77
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Swigut1">[86]</xref>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crm<sup>&#8722;</sup></italic>
###xml 304 307 304 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">129</sub>
###xml 311 314 311 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">133</sub>
###xml 321 324 321 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134</sub>
###xml 438 441 438 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 450 453 450 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 589 592 589 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 612 615 612 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 622 625 622 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mlu</italic>
###xml 666 669 666 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 678 681 678 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 893 897 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Schindler1">[87]</xref>
###xml 1040 1044 1040 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour1">[28]</xref>
###xml 1045 1049 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bour2">[30]</xref>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Nguyen2">[88]</xref>
###xml 1348 1352 1348 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Rosati1">[89]</xref>
###xml 1545 1549 1545 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Abada1">[31]</xref>
###xml 4 7 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 168 171 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 459 464 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 472 477 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 485 490 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 499 504 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 513 518 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 529 534 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 539 544 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 687 692 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 701 706 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 715 720 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 731 736 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 761 766 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 922 927 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 938 943 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1246 1249 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1386 1391 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1408 1413 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1428 1433 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
The SIV Nef expression construct pCGCG-239-Nef was provided by Dr. Jacek Skowronski (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) [86]. Constructs expressing SIV Nef mutants with amino acid substitutions in the N-terminal myristoylation site (G2A) and the cholesterol recognition motif (crm-; L129R, Y133A and Y134A) were created by site directed mutagenesis of pCGCG-239-Nef. Additional constructs expressing Nef alleles of SIVsmmFYr1, SIVsmmFWr1, HIV-2 ROD10, HIV-2 ROD14, HIV-2 CBL-23, HIV-2 60415K, HIV-1 NL4-3 and HIV-1 NA7 HIV-1 were generated by introducing PCR-amplified nef sequences into the Xba I and Mlu I sites of pCGCG. The Nef alleles of SIVsmmFYr1, SIVsmmFWr1, HIV-2 CBL-23, HIV-2 60415K, HIV-1 NL4-3 and HIV-1 NA7 were amplified from HIV-1 NL4-3 based expression constructs provided by Dr. Frank Kirchhoff (Institute of Virology, Universitatsklinikum, Ulm, Germany) [87], and the Nef alleles of HIV-2 ROD10 and HIV-2 ROD14 were amplified from pROD10 and pROD14 provided by Dr. Klaus Strebel (NIAID, Bethesda, MD) [28],[30]. The codon-optimized Vpu expression construct pcDNA-Vphu was obtained through the AIDS Research and Reference Reagent Program from Dr. Stephan Bour and Dr. Klaus Strebel [88]. The codon-optimized SIV Env expression construct 64S was obtained from Dr. George Pavlakis (NCI-Frederick, Frederick, MD) [89]. The expression constructs pSA91-HIV-2 ROD10 and pSA91-HIV-2 ROD14 for the HIV-2 ROD10 and ROD14 envelope glycoproteins were provided by Dr. Paula Cannon (Childrens Hospital, Los Angeles, CA) [31].
###end p 77
###begin title 78
Virus release assays
###end title 78
###begin p 79
###xml 124 127 124 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 559 562 559 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 566 574 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 1008 1009 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 578 583 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 642 647 <span type="species:ncbi:9606">human</span>
###xml 673 687 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 713 727 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 1226 1229 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1238 1243 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To assay for virus restriction, 293T cells were co-transfected with proviral DNA clones based on HIV-1 NL4-3 (20 ng) and SIVmac239 (100 ng) together with pcDNA3-based expression constructs for either human or rhesus tetherin (0-200 ng of pcDNA3-hBST2 or pcDNA3-rBST2). Differences in the amount of plasmid DNA in each transfection were offset by the addition of the empty pcDNA3 vector (0-200 ng). To assay for the ability of Vpu and Nef to rescue virus release in the presence of tetherin, 293T cells were co-transfected with; (1) proviral DNA for either SIVmac239 Deltanef or HIV-1 HXB2 (100 ng), (2) pcDNA3-based expression constructs for human tetherin (pcDNA3-hBST2), rhesus macaque tetherin (pcDNA3-rBST2), sooty mangabey tetherin (pcDNA3-sBST2) or an empty vector control (pcDNA3) (50 ng), and (3) expression constructs for Vpu (pcDNA-Vphu), Nef (pCGCG-239-Nef and derivatives) or vector alone (pCGCG) (100 ng). Transfections were performed in duplicate in 24-well plates seeded the day before at 5x104 cells per well using GenJet Lipid Transfection Reagents (SignaGen Laboratories, Gaithersburg, MD). Forty-eight hours after transfection, the amount of virus released into the cell culture supernatant was measured by SIV p27 and HIV-1 p24 antigen-capture ELISA (Advanced Bioscience Laboratories, Inc., Kensington, MD). The percentage of maximal particle release was calculated by dividing the mean p24/p27 release in the presence of tetherin by the mean p24/p27 release in the absence of tetherin and multiplying by 100.
###end p 79
###begin title 80
Infectivity assays
###end title 80
###begin p 81
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Bogerd1">[50]</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Morner1">[53]</xref>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 205 210 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 215 218 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 626 631 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 635 638 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The amount of infectious virus present in the cell culture supernatant was measured by infection of GHOST X4/R5 cells [50]. These cells harbor a Tat-inducible GFP reporter gene and are susceptible to both HIV-1 and SIV infection by virtue of expressing CD4, CXCR4 and CCR5. The GHOST (3) X4/R5 cells were obtained through the AIDS Research and Reference Reagent Program from Dr. Vineet N. KewalRamani and Dr. Dan R. Littman [53]. These cells were seeded at 2.5x104 cells per well in 24-well plates, and infected the following day by replacing the medium with 100 microl of culture supernatant from 293T cells transfected with HIV-1 or SIV proviral DNA. After 2 hours, the culture volume was brought to 2 ml with fresh medium. Forty-eight hours later, the cells were trypsinized, fixed in 2% paraformaldehyde/PBS and analyzed by flow cytometry. The data were collected using a FACSCalibur flow cytometer (Becton Dickenson, San Jose, CA) and analyzed using FlowJo 8.7 software (TreeStar, San Carlos, CA).
###end p 81
###begin title 82
Western blots
###end title 82
###begin p 83
###xml 1736 1739 1721 1724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 2591 2595 2576 2580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Jouvenet1">[27]</xref>
###xml 639 642 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 715 720 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 763 768 <span type="species:ncbi:9606">Human</span>
###xml 934 937 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1015 1018 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1093 1098 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1122 1128 <span type="species:ncbi:9986">rabbit</span>
###xml 1141 1146 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1178 1183 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1227 1233 <span type="species:ncbi:9986">rabbit</span>
###xml 1388 1391 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1397 1400 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1406 1411 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1417 1422 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1428 1433 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1442 1447 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1558 1561 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1571 1586 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 1764 1769 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1934 1939 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 2049 2053 <span type="species:ncbi:9925">goat</span>
###xml 2059 2064 <span type="species:ncbi:10090">mouse</span>
###xml 2095 2099 <span type="species:ncbi:9925">goat</span>
###xml 2105 2111 <span type="species:ncbi:9986">rabbit</span>
Virions were recovered from cell culture supernatants at 13,000 rpm for 2 hours at 4degreesC and virus pellets were resuspended in 2x sodium dodecyl sulfate (SDS) sample buffer. Cell lysates were prepared by harvesting cells in 2x SDS sample buffer. Samples were boiled for 5 minutes, separated by electrophoresis on 10% SDS-polyacrylamide gels and transferred to polyvinylidene fluoride (PVDF) membranes using a Trans-Blot SD semidry transfer cell (Bio-Rad, Hercules, CA). The membranes were then blocked in 5% non-fat milk-PBS containing 0.05% Tween-20 for 1 hour and probed overnight with the following primary antibodies at 4degreesC. SIV p27 and p55 were detected using a cross-reactive monoclonal antibody to HIV-1 p24 (183-H12-5C) at a dilution of 1:1000. Human and rhesus tetherin were detected using the monoclonal antibody HM1.24, generously provided by Chugai Pharmaceutical Co. (Kanagawa, Japan), at a dilution of 1:2000. SIV Nef was detected using the 17.2 monoclonal antibody at a dilution of 1:1000. SIV Env was detected using the KK42 monoclonal antibody at a 1:1000 dilution. HIV-2 Env was detected using rabbit antisera to HIV-2 ST gp120 at a 1:1000 dilution. HIV-1 Nef and Vpu were detected using polyclonal rabbit sera at dilutions of 1:500. beta-actin was detected using the monoclonal antibody C4 (Chemicon, Billerica, MA) at a dilution of 1:1000. The antibodies to SIV Nef, SIV Env, HIV-2 Env, HIV-1 p24, HIV-1 Nef and HIV-1 Vpu were all obtained through the AIDS Research and Reference Reagent Program, NIAID, NIH. Pooled plasma from SIV-infected sooty mangabeys, provided by Dr. Amitinder Kaur (New England Primate Research Center, Harvard Medical School), was used at dilution of 1:200 for the detection of SIVsmm Nef. Pooled plasma from HIV-2-infected individuals, provided by Dr. Walid Heneine (Centers for Disease Control and Prevention, Atlanta, GA), was used at a dilution of 1:200 for the detection of HIV-2 Nef. After washing in PBS 0.05% Tween-20, blots were probed with HRP-conjugated secondary antibodies, either goat anti-mouse IgG (Pierce, Rockford, IL) or goat anti-rabbit IgG (Sigma), at dilutions of 1:2000 for 1 hour. Blots were then washed, developed with SuperSignal West Femto Maximum Sensitivity substrate (Pierce), and bands were visualized using a Fujifilm Image Reader LAS 3000 phosphoimager (Fujifilm Photo Film Co., Japan). The pixel intensities for the p27 and p55 bands in virions and cell lysates respectively were determined using the Image J Software (Rasband, W.S., Image, U.S. NIH, Bethesda, MD, , 1997-2008) as previously described [27].
###end p 83
###begin title 84
Downregulation assay
###end title 84
###begin p 85
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mlu</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rBST2</italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hBST2</italic>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BST2</italic>
###xml 393 396 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Age</italic>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pac</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
Stable 293T cell lines expressing HA-tagged human and rhesus tetherin were established by retroviral transduction. An oligonucleotide encoding the HA tag was inserted in-frame into the Mlu I sites of rBST2 and hBST2 resulting in the introduction of the 9 amino acid HA epitope after residue 131 of hBST2 and after residue 134 rBST2. These HA-tagged BST2 sequences were then subcloned into the Age I and Pac I sites of the retroviral vector pQCXIP (Clonetech Laboratories, Mountainview, CA). VSV G-pseudotyped MLV particles packaging these vectors were produced by co-transfection of GP2-293 cells with pVSV-G and used to infect 293T cells. Stable cell lines were selected in medium containing puromycin (4 microg/ml) and enriched for BST2 expression by FACS after staining with the PE-conjugated, anti-HA monoclonal antibody HA.11 (Covance, Emeryville, CA).
###end p 85
###begin p 86
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 410 416 <span type="species:ncbi:9793">donkey</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
Cells expressing HA-tagged human and rhesus tetherin were plated at a density of 5x104 cells per well in 24 well plates and transfected the following day with pCGCG-based constructs (200 ng) that co-express Nef and GFP. After 24 hours, the cells were trypsinized and stained with the anti-HA monoclonal antibody HA.11 for 30 minutes at 4degreesC. The cells were then washed and stained with an APC-conjugated, donkey anti-mouse IgG polyclonal antibody (eBioscience, San Diego, CA) for 30 minutes at 4degreesC. The cells were washed, fixed in 2% paraformaldehyde PBS and analyzed using a FACSCalibur flow cytometer (Becton Dickenson, San Jose, CA). The data were analyzed using FlowJo 8.7 software (TreesStar, San Carlos, CA).
###end p 86
###begin title 87
###xml 71 79 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 88 104 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 67 70 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 84 87 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Infection of interferon-treated sMAGI cells with VSV G-pseudotyped SIV Deltaenv and SIV DeltaenvDeltanef
###end title 87
###begin p 88
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000429-Chackerian1">[90]</xref>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 376 384 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env</italic>
###xml 393 409 385 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;env&#916;nef</italic>
###xml 4 18 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 372 375 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 389 392 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The rhesus macaque sMAGI cell line was obtained through the AIDS Research and Reference Reagent Program from Dr. Julie Overbaugh [90]. Cells were seeded to 24 well plates at a density of 1x105 cells per well in medium lacking or containing 1000 U/ml IFNalpha (Sigma, St. Louis, MO). The following day, duplicate wells were infected with 50 ng p27 eq. of VSV G-pseudotyped SIV Deltaenv and SIV DeltaenvDeltanef. The medium was replaced after 24 hours continuing with or without IFNalpha. On day 3 post-infection, the accumulation of p27 in the cell culture supernatant was measured by antigen capture ELISA. The upregulation of tetherin in response to IFNalpha was assessed by staining sMAGI cells with a FITC-conjugated monoclonal antibody to tetherin (Chugai Pharmaceutical Co.).
###end p 88
###begin title 89
Genbank accession numbers
###end title 89
###begin p 90
###xml 100 103 100 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 124 127 124 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 151 154 151 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smm</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 25 39 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 61 75 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 175 180 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 204 209 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 233 238 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 259 264 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human tetherin [D28137]; rhesus macaque tetherin [FJ868941]; sooty mangabey tetherin [FJ864713]; SIVmac239 Nef [M33262]; SIVsmmFYr1 Nef [DQ092760]; SIVsmmFWr1 Nef [DQ092758]; HIV-2 CBL-23 Nef [DQ222472]; HIV-2 60415K Nef [DQ092764]; HIV-1 NL4-3 Nef [M19921]; HIV-1 NA7 Nef [DQ242535].
###end p 90
###begin p 91
###xml 184 192 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;vpu</italic>
###xml 200 203 196 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 207 215 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;nef</italic>
###xml 172 177 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We thank Swee Kee Wong and Julieta Manrique in the Division of Microbiology, New England Primate Research Center (NEPRC), for providing the full-length molecular clones of HIV-1 NL4-3 Deltavpu and SIVmac239 Deltanef. We also thank Jackie Gillis and Michelle Connole in the Division of Immunology, NEPRC, for flow cytometry services.
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
###end article-title 93
###begin article-title 94
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral vpu protein.
###end article-title 94
###begin article-title 95
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel gene of HIV-1, vpu, and its 16-kilodalton product.
###end article-title 95
###begin article-title 96
###xml 38 73 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein.
###end article-title 96
###begin article-title 97
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Functional role of human immunodeficiency virus type 1 vpu.
###end article-title 97
###begin article-title 98
###xml 4 39 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release.
###end article-title 98
###begin article-title 99
Cell type-dependence for Vpu function.
###end article-title 99
###begin article-title 100
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Function of human immunodeficiency virus type 1 Vpu protein in various cell types.
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.
###end article-title 101
###begin article-title 102
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production.
###end article-title 102
###begin article-title 103
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 67 78 <span type="species:ncbi:205488">Ebola virus</span>
###xml 123 128 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 vpu protein.
###end article-title 103
###begin article-title 104
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
###end article-title 104
###begin article-title 105
Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology.
###end article-title 105
###begin article-title 106
Clatharin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif.
###end article-title 106
###begin article-title 107
###xml 38 66 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Lipid composition and fluidity of the human immunodeficiency virus.
###end article-title 107
###begin article-title 108
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.
###end article-title 108
###begin article-title 109
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Plasma membrane rafts play a critical role in HIV-1 assembly and release.
###end article-title 109
###begin article-title 110
Influenza viruses select ordered lipid domains during budding from the plasma membrane.
###end article-title 110
###begin article-title 111
###xml 49 60 <span type="species:ncbi:205488">Ebola virus</span>
In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding.
###end article-title 111
###begin article-title 112
Virus kept on a leash.
###end article-title 112
###begin article-title 113
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 23 33 <span type="species:ncbi:9598">chimpanzee</span>
###xml 34 49 <span type="species:ncbi:9598">Pan troglodytes</span>
Origin of HIV-1 in the chimpanzee Pan troglodytes.
###end article-title 113
###begin article-title 114
###xml 28 57 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 165 193 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Ceropithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny.
###end article-title 114
###begin article-title 115
###xml 17 20 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 24 35 <span type="species:ncbi:9598">chimpanzees</span>
Hybrid origin of SIV in chimpanzees.
###end article-title 115
###begin article-title 116
###xml 24 53 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 125 132 <span type="species:ncbi:36226">C. mona</span>
###xml 134 143 <span type="species:ncbi:270015|species:ncbi:9535">C. cephus</span>
###xml 149 161 <span type="species:ncbi:225969|species:ncbi:36228">C. nictitans</span>
Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different Cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon.
###end article-title 116
###begin article-title 117
Inhibition of Lassa and Marburg virus production by tetherin.
###end article-title 117
###begin article-title 118
Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
###end article-title 118
###begin article-title 119
Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.
###end article-title 119
###begin article-title 120
###xml 29 64 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a vpu-like factor?
###end article-title 120
###begin article-title 121
###xml 0 35 <span type="species:ncbi:11709">Human immunodeficiency virus type 2</span>
Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.
###end article-title 121
###begin article-title 122
###xml 52 57 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release.
###end article-title 122
###begin article-title 123
###xml 30 65 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
Functional domains within the human immunodeficiency virus type 2 envelope glycoprotein required to enhance virus production.
###end article-title 123
###begin article-title 124
###xml 57 62 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
An African primate lentivirus (SIVsm) closely related to HIV-2.
###end article-title 124
###begin article-title 125
###xml 45 80 <span type="species:ncbi:11712">simian immunodeficiency virus SIVsm</span>
###xml 125 128 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 238 252 <span type="species:ncbi:9531">sooty mangabey</span>
Genetic characterization of new West African simian immunodeficiency virus SIVsm: Geographic clustering of household-derived SIV strains with human immundeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop.
###end article-title 125
###begin article-title 126
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.
###end article-title 126
###begin article-title 127
AIDS as a Zoonosis: Scientific and public health implications.
###end article-title 127
###begin article-title 128
###xml 11 40 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center.
###end article-title 128
###begin article-title 129
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
###end article-title 129
###begin article-title 130
Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain.
###end article-title 130
###begin article-title 131
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
TRIM5alpha restricts HIV-1 infection in Old World monkeys.
###end article-title 131
###begin article-title 132
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A single amino acid in the SPRY domain of human TRIM5alpha leads to HIV-1 restriction.
###end article-title 132
###begin article-title 133
###xml 93 121 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
###end article-title 133
###begin article-title 134
Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
###end article-title 134
###begin article-title 135
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
###end article-title 135
###begin article-title 136
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
###end article-title 136
###begin article-title 137
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 50 85 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
###end article-title 137
###begin article-title 138
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 79 84 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.
###end article-title 138
###begin article-title 139
Intracellular restriction factors in mammalian cells - an ancient defense system finds a modern foe.
###end article-title 139
###begin article-title 140
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (vif).
###end article-title 140
###begin article-title 141
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 99 104 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A single amino acid substitution in the human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
###end article-title 141
###begin article-title 142
###xml 104 107 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.
###end article-title 142
###begin article-title 143
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.
###end article-title 143
###begin article-title 144
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor.
###end article-title 144
###begin article-title 145
###xml 8 43 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
###xml 45 50 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
###end article-title 145
###begin article-title 146
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions.
###end article-title 146
###begin article-title 147
###xml 41 46 <span type="species:ncbi:9606">human</span>
The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable.
###end article-title 147
###begin article-title 148
###xml 32 67 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intract nef gene.
###end article-title 148
###begin article-title 149
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.
###end article-title 149
###begin article-title 150
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
###end article-title 150
###begin article-title 151
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
###end article-title 151
###begin article-title 152
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef: Adapting to intracellular trafficking pathways.
###end article-title 152
###begin article-title 153
###xml 27 62 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutational analysis of the human immunodeficiency virus type 1 vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells.
###end article-title 153
###begin article-title 154
###xml 74 109 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 vpu protein.
###end article-title 154
###begin article-title 155
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The two biological activities of human immunodeficiency virus type 1 vpu protein involve separable structural domains.
###end article-title 155
###begin article-title 156
Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cel growth.
###end article-title 156
###begin article-title 157
###xml 24 34 <span type="species:ncbi:9598">chimpanzee</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
Initial sequence of the chimpanzee genome and comparison with the human genome.
###end article-title 157
###begin article-title 158
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The nef protein of HIV-1 associates with rafts and primes T cells for activation.
###end article-title 158
###begin article-title 159
###xml 29 32 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Nef increases infectivity of HIV via lipid rafts.
###end article-title 159
###begin article-title 160
Importance of the nef gene for maintenance of high virus loads and for the development of AIDS.
###end article-title 160
###begin article-title 161
###xml 47 76 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Identification of highly attenuated mutants of simian immunodeficiency virus.
###end article-title 161
###begin article-title 162
###xml 49 78 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Downregulation of cell-surface CD4 expression by simian immunodeficiency virus nef prevents viral super infection.
###end article-title 162
###begin article-title 163
###xml 28 42 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 47 61 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 131 160 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 165 200 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
Selective downregulation of rhesus macaque and sooty mangabey major histocompatibility complex class I molecules by nef alleles of simian immunodeficiency virus and human immunodeficiency virus type 2.
###end article-title 163
###begin article-title 164
###xml 19 48 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 53 88 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.
###end article-title 164
###begin article-title 165
###xml 21 35 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 53 82 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 101 136 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1.
###end article-title 165
###begin article-title 166
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
###end article-title 166
###begin article-title 167
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Generation of simian-tropic HIV-1 by restriction factor evasion.
###end article-title 167
###begin article-title 168
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells.
###end article-title 168
###begin article-title 169
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 54 83 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 135 154 <span type="species:ncbi:9545">pig-tailed macaques</span>
Human immunodeficency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques.
###end article-title 169
###begin article-title 170
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A macaque model of HIV-1 infection.
###end article-title 170
###begin article-title 171
Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
###end article-title 171
###begin article-title 172
###xml 21 35 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 58 87 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.
###end article-title 172
###begin article-title 173
###xml 68 97 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.
###end article-title 173
###begin article-title 174
###xml 31 34 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIVmac239.
###end article-title 174
###begin article-title 175
###xml 80 85 <span type="species:ncbi:9606">human</span>
Production of acquired immunodeficiency virus syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
###end article-title 175
###begin article-title 176
A molecular clone of HTLV-III with biological activity.
###end article-title 176
###begin article-title 177
###xml 54 64 <span type="species:ncbi:11676">AIDS virus</span>
Complete nucleotide sequences of functional clones of AIDS virus.
###end article-title 177
###begin article-title 178
###xml 11 39 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Simian and human immunodeficiency virus nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.
###end article-title 178
###begin article-title 179
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1.
###end article-title 179
###begin article-title 180
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Codon optimization of the HIV-1 vpu and vif genes stabilizes their messenger RNA and allows for highly efficient Rev-independent expression.
###end article-title 180
###begin article-title 181
###xml 43 72 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.
###end article-title 181
###begin article-title 182
###xml 141 170 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
###end article-title 182
###begin p 183
The authors have declared that no competing interests exist.
###end p 183
###begin p 184
This work was supported by Public Health Service grants AI063993 and AI071306 from the National Institutes of Health. DTE is an Elizabeth Glaser Scientist supported by the Elizabeth Glaser Pediatric AIDS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 184

